机构:[1]College of Biomedical Engineering, Sichuan University, Chengdu 610065 China[2]Laboratory of Controllable Preparation and Application of Nanomaterials, Technical Institute of Physics and Chemistry, Chinese Academy of Sciences, Beijing 100190, China[3]Department of Radiology, First Hospital of China Medical University, Shenyang 110001, China
The authors acknowledge financial support from the National Natural Science Foundation of China (No. U20A20335, 91859201, 62001456), the Beijing Natural Science Foundation (Project No. 7212208, 4222019).
语种:
外文
PubmedID:
中科院(CAS)分区:
出版当年[2022]版:
大类|2 区工程技术
小类|2 区材料科学:生物材料2 区生物物理2 区物理化学
最新[2023]版:
大类|2 区医学
小类|1 区生物物理2 区物理化学3 区材料科学:生物材料
第一作者:
第一作者机构:[1]College of Biomedical Engineering, Sichuan University, Chengdu 610065 China[2]Laboratory of Controllable Preparation and Application of Nanomaterials, Technical Institute of Physics and Chemistry, Chinese Academy of Sciences, Beijing 100190, China
通讯作者:
推荐引用方式(GB/T 7714):
Zeng Zhiheng,Sun Xiaohan,Huang Zhongbing,et al.A multifunctional nanoplatform for improving microwave hyperthermia by a combination therapy of vessel disruptive agent and immune modulator.[J].Colloids and surfaces. B, Biointerfaces.2022,217:112616.doi:10.1016/j.colsurfb.2022.112616.
APA:
Zeng Zhiheng,Sun Xiaohan,Huang Zhongbing,Fu Changhui,Ren Jun...&Meng Xianwei.(2022).A multifunctional nanoplatform for improving microwave hyperthermia by a combination therapy of vessel disruptive agent and immune modulator..Colloids and surfaces. B, Biointerfaces,217,
MLA:
Zeng Zhiheng,et al."A multifunctional nanoplatform for improving microwave hyperthermia by a combination therapy of vessel disruptive agent and immune modulator.".Colloids and surfaces. B, Biointerfaces 217.(2022):112616